These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 38360184)

  • 1. Effect of rifampicin administration on CYP induction in a dermatomyositis patient with vasospastic angina attributable to nilmatrelvir/ritonavir-induced blood tacrolimus elevation: A case report.
    Akamatsu H; Kohno Y; Hashizume J; Nakagawa H; Kodama Y; Kawano H; Maemura K; Ohyama K
    J Infect Chemother; 2024 Sep; 30(9):928-933. PubMed ID: 38360184
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of ensitrelvir or nirmatrelvir/ritonavir on tacrolimus clearance in kidney transplant recipients: a single-center case series.
    Naganawa H; Katada Y; Nakagawa S; Umemura K; Ishimura H; Kajiwara M; Endo H; Sugimoto M; Katsube Y; Kotani K; Ohta S; Hira D; Tsuda M; Kita Y; Kobayashi T; Terada T
    J Pharm Health Care Sci; 2024 Jul; 10(1):37. PubMed ID: 38987842
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nirmatrelvir/ritonavir-induced elevation of blood tacrolimus levels in a patient in the maintenance phase post liver transplantation.
    Shiohira H; Arakaki S; Uehara W; Uehara H; Yamamoto K; Nakamura K
    J Infect Chemother; 2024 Jan; 30(1):77-80. PubMed ID: 37689137
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phenytoin enzyme induction for management of supratherapeutic tacrolimus levels due to drug-drug interaction with nirmatrelvir/ritonavir: Case series and discussion.
    Marsh J; Logan AT; Bilgili EP; Bowman LJ; Webb AR
    Am J Health Syst Pharm; 2024 Jun; 81(13):e345-e352. PubMed ID: 38347740
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nirmatrelvir/ritonavir treatment of patients with COVID-19 taking tacrolimus: case series describing the results of drug-drug interactions.
    Shen D; Gong Y; Qian Y; Zhu J; Gao J
    J Int Med Res; 2024 May; 52(5):3000605241247705. PubMed ID: 38698526
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nirmatrelvir/ritonavir treatment in SARS-CoV-2 positive kidney transplant recipients - a case series with four patients.
    Schneider J; Wobser R; Kühn W; Wagner D; Tanriver Y; Walz G
    BMC Nephrol; 2023 Apr; 24(1):99. PubMed ID: 37061677
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management and Outcome of COVID-19 Infection Using Nirmatrelvir/Ritonavir in Kidney Transplant Patients.
    Giguère P; Deschenes MJ; Van Loon M; Hoar S; Fairhead T; Pazhekattu R; Knoll G; Karpinski J; Parikh N; McDougall J; McGuinty M; Hiremath S
    Clin J Am Soc Nephrol; 2023 Jul; 18(7):913-919. PubMed ID: 37099447
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Abnormally Elevated Blood Tacrolimus Level Following the Concomitant Use of Nirmatrelvir/Ritonavir With Extended-Release Tacrolimus in a Post-lung Transplant Patient: A Case Report and a Literature Review.
    Yoshida H; Umemura T; Ito S; Mizuno T; Mutoh Y; Yamada T; Kimura T
    Cureus; 2024 Jun; 16(6):e62868. PubMed ID: 39040776
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tacrolimus Drug-Drug Interaction with Nirmatrelvir/Ritonavir (Paxlovid™) Managed with Phenytoin.
    Sindelar M; McCabe D; Carroll E
    J Med Toxicol; 2023 Jan; 19(1):45-48. PubMed ID: 36536192
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Paxlovid (Nirmatelvir/Ritonavir) and Tacrolimus Drug-Drug Interaction in a Kidney Transplant Patient with SARS-2-CoV infection: A Case Report.
    Prikis M; Cameron A
    Transplant Proc; 2022; 54(6):1557-1560. PubMed ID: 35599203
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A case report of a prolonged decrease in tacrolimus clearance due to co-administration of nirmatrelvir/ritonavir in a lung transplant recipient receiving itraconazole prophylaxis.
    Tsuzawa A; Katada Y; Umemura K; Sugimoto M; Nishikawa A; Sato YK; Yoshida Y; Kitada N; Yonezawa A; Nakajima D; Date H; Terada T
    J Pharm Health Care Sci; 2023 Apr; 9(1):12. PubMed ID: 37004119
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute acalculous cholecystitis following extended administration of nirmatrelvir/ritonavir for persistent SARS-CoV-2 infection.
    Ito W; Fukumori T; Asaoka N; Imakita N; Nishimura T; Furukawa R; Nishihara Y; Fujikura H; Sekine T; Yamaguchi N; Hirata Y; Miyamoto S; Kanno T; Katano H; Suzuki T; Kasahara K
    J Infect Chemother; 2024 Jul; 30(7):659-663. PubMed ID: 38184107
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical significance of plasma concentration of macrophage colony-stimulating factor in patients with vasospastic angina].
    Tomimura M; Saitoh T; Kishida H; Kusama Y; Takano T
    J Cardiol; 2002 Jan; 39(1):19-27. PubMed ID: 11828794
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Case report and literature review: management of Paxlovid (nirmatrelvir/ritonavir)-induced acute tacrolimus toxicity in a patient with systemic lupus erythematosus.
    Jiang C; Yan X; Xia P; Luo X; Zheng H; Tong H; Liu Y; Zhu H; Xu P; Wang J
    Front Pharmacol; 2024; 15():1364121. PubMed ID: 38962309
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Case report: Supratherapeutic tacrolimus concentrations with nirmatrelvir/ritonavir in a lung transplant patient: a case report using Rifampin for reversal.
    Xiong Y; Wang X; Li S; Zhang Q; Guo L; Chen W; Zhao Z; Liu L
    Front Pharmacol; 2023; 14():1285078. PubMed ID: 38026995
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A model-based pharmacokinetic assessment of drug-drug interaction between tacrolimus and nirmatrelvir/ritonavir in a kidney transplant patient with COVID-19.
    Tomida T; Itohara K; Yamamoto K; Kimura T; Fujita K; Uda A; Kitahiro Y; Yokoyama N; Hyodo Y; Omura T; Yano I
    Drug Metab Pharmacokinet; 2023 Dec; 53():100529. PubMed ID: 37924724
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug-drug interaction of Nirmatrelvir/ritonavir and tacrolimus: A potential risk disproportionality analysis of nephrotoxicity from COVID-19 reports in FAERS.
    Qin F; Wang H; Li M; Zhuo S; Liu W
    Expert Opin Drug Saf; 2023; 22(12):1321-1327. PubMed ID: 37477905
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of sarpogrelate and high-dose statin on the reduction of coronary spasm in vasospastic angina: A two by two factorial, pilot randomized study.
    Kim SR; Choi KH; Song YB; Lee JM; Park TK; Yang JH; Hahn JY; Choi JH; Choi SH; Gwon HC
    Clin Cardiol; 2019 Oct; 42(10):899-907. PubMed ID: 31339594
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug interactions between common dermatological medications and the oral anti-COVID-19 agents nirmatrelvir-ritonavir and molnupiravir.
    Quah KSE; Huang X; Renia L; Oon HH
    Ann Acad Med Singap; 2022 Dec; 51(12):774-786. PubMed ID: 36592146
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vasospastic angina: a review on diagnostic approach and management.
    Jenkins K; Pompei G; Ganzorig N; Brown S; Beltrame J; Kunadian V
    Ther Adv Cardiovasc Dis; 2024; 18():17539447241230400. PubMed ID: 38343041
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.